Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04907851
Title A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Redx Pharma Plc
Indications

ampulla of Vater cancer

pancreatic ductal adenocarcinoma

extrahepatic bile duct carcinoma

biliary tract cancer

intrahepatic cholangiocarcinoma

gallbladder cancer

Therapies

Denosumab + RXC004

Age Groups: adult | senior
Covered Countries


No variant requirements are available.